In reality, if they do have the sublingual tablet
Post# of 15624
(Total Views: 249)
Posted On: 04/18/2017 1:22:43 PM
Re: DigitalTradz #7170
In reality, if they do have the sublingual tablet on the market, MM patients will be able to give it a try and see if their condition improves.
OWCP is making the technology available, before proving it works in certain specific cases, because it will work in ways that are acceptable for sale, at least in Green Cross stores.
I'd suspect that they may find that the precise cannabis form they're using in the sublingual tablets needs to change to be most effective against MM, but essentially it will be nearly the same product that should be available in months. It will take several years of clinical trials to prove this true, or perhaps to find that what works preclinically doesn't work in the clinic, time will tell.
History demonstrates that roughly 30% of the products that enter the clinic in Phase 1 clinical trials are approved. It often takes a decade or longer to go from Phase 1 to Phase 3 and approval, and the cost is normally in the hundreds of millions by the time of the approval. OWCP is approaching this in just the opposite way that big Pharma does, the product will be available first, then they'll prove it works. This is possible because of the bizarre approach we take to plant and mineral based products, especially cannabis based.
If this were a chemical product produced in a lab, it couldn't be sold. Because it's a natural product extracted from plants, it can be. I believe it's that confusion in the Annual Report that has the stock down today, but it will become clear in a few months as our cannabis cream becomes available in Green Cross stores.
Gary
OWCP is making the technology available, before proving it works in certain specific cases, because it will work in ways that are acceptable for sale, at least in Green Cross stores.
I'd suspect that they may find that the precise cannabis form they're using in the sublingual tablets needs to change to be most effective against MM, but essentially it will be nearly the same product that should be available in months. It will take several years of clinical trials to prove this true, or perhaps to find that what works preclinically doesn't work in the clinic, time will tell.
History demonstrates that roughly 30% of the products that enter the clinic in Phase 1 clinical trials are approved. It often takes a decade or longer to go from Phase 1 to Phase 3 and approval, and the cost is normally in the hundreds of millions by the time of the approval. OWCP is approaching this in just the opposite way that big Pharma does, the product will be available first, then they'll prove it works. This is possible because of the bizarre approach we take to plant and mineral based products, especially cannabis based.
If this were a chemical product produced in a lab, it couldn't be sold. Because it's a natural product extracted from plants, it can be. I believe it's that confusion in the Annual Report that has the stock down today, but it will become clear in a few months as our cannabis cream becomes available in Green Cross stores.
Gary
(0)
(0)OWC Pharmaceutical Research Corp. (OWCP) Stock Research Links
Scroll down for more posts ▼